TCOK
HUMA icon

Trust Company of Kansas’s Humacyte HUMA Stock Holding History

Trust Company of Kansas’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Hold
24,000
– – 0.01% 59
2026
Q1 		$15K Buy
24,000
+4,000
+20% +$4.16K 0.01% 56
2025
Q4 		$19K Buy
20,000
+4,000
+25% +$5.66K 0.01% 55
2025
Q3 		$28K Buy
+16,000
New +$31.3K 0.01% 61

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
EWM
Endowment Wealth Management Appleton, Wisconsin $259M AUM 15.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Trust Company of Kansas's HUMA Position: Q2 2026 in Review

Trust Company of Kansas held its Humacyte (HUMA) position steady in Q2 2026 at 24,000 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #59.

Trust Company of Kansas first reported a position in HUMA in Q3 2025 and has held it in 4 quarters since. The position peaked at $28K in Q3 2025. 59 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Trust Company of Kansas held 24,000 shares of Humacyte worth $19K as of Q2 2026.
  • Trust Company of Kansas left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up 0.01% of Trust Company of Kansas's portfolio in Q2 2026, its #59 holding.
  • Trust Company of Kansas first reported a position in Humacyte in Q3 2025 and has held it in 4 quarters since.
  • Trust Company of Kansas's Humacyte position peaked at $28K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Trust Company of Kansas's 13F filing for Q2 2026, filed 22 Jul 2026.